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Background: A detailed description of the kinetics of deneddylation of cullin by CSN has been lacking.
Results: Selected factors and SCF subunits are able to inhibit deneddylation to varying degrees. CSN interferes with SCF-
mediated ubiquitination through a noncatalytic mechanism.
Conclusion: Deneddylation of Cul1 by CSN is regulated by F-box protein, substrate, and other factors.
Significance:Our work reported here could facilitate the development of directed therapies.
COP9 signalosome (CSN) mediates deconjugation of the
ubiquitin-like protein Nedd8 from the cullin subunits of SCF
and other cullin-RING ubiquitin ligases (CRLs). This process is
essential to maintain the proper activity of CRLs in cells. Here,
we report a detailed kinetic characterization of CSN-mediated
deconjugation of Nedd8 from SCF. CSN is an efficient enzyme,
with a kcat of1 s1 and Kmfor neddylated Cul1-Rbx1 of200
nM, yielding a kcat/Km near the anticipated diffusion-controlled
limit. Assembly with an F-box-Skp1 complex markedly inhib-
ited deneddylation, although the magnitude varied consider-
ably, with Fbw7-Skp1 inhibiting by 5-fold but Skp2-Cks1-
Skp1 by only 15%. Deneddylation of both SCFFbw7 and
SCFSkp2-Cks1 was further inhibited 2.5-fold by the addition of
substrate. Combined, the inhibition by Fbw7-Skp1 plus its sub-
strate cyclin E was greater than 10-fold. Unexpectedly, our
results also uncover significant product inhibition by deconju-
gated Cul1, which results from the ability of Cul1 to bind tightly
to CSN. Reciprocally, CSN inhibits the ubiquitin ligase activity
of deneddylated Cul1. We propose a model in which assembled
CRL complexes engaged with substrate are normally refractory
to deneddylation. Upon consumption of substrate and subse-
quent deneddylation, CSN can remain stably bound to the CRL
and hold it in low state of reduced activity.
Cullin-RING ubiquitin ligases (CRLs)4 are heteromeric
enzymes comprising cullin, RINGdomain, and substrate recep-
tor subunits (1, 2). The cullin subunit serves as the backbone of
the enzyme, displaying on one end a substrate receptor com-
plex that recruits substrates for ubiquitylation and on the other
end a RING domain subunit (Rbx1/Roc1/Hrt1) that recruits a
ubiquitin-conjugating enzyme that transfers ubiquitin to
substrate.
CRLs comprise a family of up to 240 enzymes that exert a
profound effect on eukaryotic cells and organisms. CRLs, in
aggregate, appear to account for 20% of total protein degra-
dation by the ubiquitin-proteasome system (3) and have been
implicated in myriad processes that underlie normal develop-
ment and physiology (4). CRLs and the pathways they control
are also prominent targets of mutation in human diseases. For
example, the most common genetic defect observed in colon
cancer is of the APC pathway, which mediates degradation of
-catenin via the CRL known as SCF-TrCP (5). Likewise, the
CRL subunit Fbw7/Cdc4 is a prominent human tumor suppres-
sor gene (6). Given their central roles in controlling numerous
cellular processes, there is considerable impetus to understand
how CRLs work and how they are regulated. Althoughmuch of
the regulation inCRLpathways is focused on the substrates, the
CRLs themselves are well documented to be regulated by con-
jugation of the cullin subunit with the ubiquitin-like protein,
Nedd8 (7, 8).
The COP9 signalosome is an 8-subunit complex that was
originally discovered based on its role in controlling light-reg-
ulated development in Arabidopsis thaliana (9). Insight into
the molecular basis of CSN action began to emerge with the
finding that in human cells, CSN forms a stable complex with a
particular subfamily of CRLs known as SCF ubiquitin ligases
(10). A similar interactionwas also detected inArabidopsis (11).
Importantly, CSNwas shown to control Nedd8modification of
the Cul1 subunit of SCF (10). Whereas 10–20% of Cul1 is
typically modified with Nedd8 in wild type Schizosaccharomy-
ces pombe, in CSN-deficient cells the entire population of Cul1
is neddylated. The reason for this is that CSN-deficient cells
lack an enzymatic activity that deconjugates Nedd8 from Cul1
(i.e., deneddylates). Subsequently, it was shown that this enzy-
matic activity resides within the Csn5 subunit of CSN and is
specified by a novel metalloenzyme motif referred to as the
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JAMM domain (12). It is now widely appreciated that CSN
mediates deneddylation of all cullins and appears to be the only
enzyme capable of doing so with good efficiency (7, 8).
In vitro, CSN inhibits CRL activity (13). This can be readily
understood, because conjugation of Nedd8 to Cul1 stimulates
the activity of SCF (14–17). However, multiple lines of genetic
evidence indicate that CSN is required to sustain CRL activity
in cells (7). This apparent paradox is resolved by the observa-
tion that CSN-mediated inactivation of CRLs counteracts auto-
catalytic breakdown of substrate receptor subunits (18–20).
Thus, the principal physiological function of CSN appears to be
to sustain optimal levels of CRL activity.
Several lines of evidence point towardCSNplaying an impor-
tant role in human cancer and potentially being a novel molec-
ular target for cancer therapy. The catalytic subunit of CSN,
Csn5, is overproduced in many human cancers, and its over-
production often correlates with poor survival (21). Interest-
ingly, the coding region for Csn5 is co-amplified alongwith that
for c-Myc in some aggressive humanbreast cancers (22). Simul-
taneous overexpression of the two proteins synergistically acti-
vates c-Myc target genes, implicating Csn5 as a positive regu-
lator of c-Myc. Moreover, expression of a catalytically inactive
mutant of Csn5 greatly attenuates growth of a c-Myc-driven
tumor in mice (23). Likewise, knockdown of Csn5 suppresses
growth of hepatocellular carcinoma in mice (24). Finally, four
subunits of CSN were shown to be required for the growth of
human colon cancer cells that express GTPase mutant K-Ras,
but not of isogenic cells in which the oncogenicKRAS allele was
deleted (25). Taken together, these results suggest that CSN
promotes cancer and nominate Csn5 as a target for cancer
therapy.
To successfully target CSN in cancer will require a better
understanding of how CSN works in cells, which in turn will
require a better quantitative understanding of the biochemical
properties of CSN.Although it has been known for 10 years that
CSN catalyzes the removal of Nedd8 from Cul1, the quantita-
tive parameters for this reaction have yet to be described,
because of the complexity of both the enzyme and its substrate.
Here, we establish enzyme and substrate preparations and
quantitative biochemical assays that allowed us to measure the
steady-state kinetic parameters for substrate deneddylation by
CSN. Our most important finding is that different F-box pro-
teins can directly inhibit deneddylation of their Cul1 partner to
variable extents, and this inhibition is potentiated upon binding
of substrate. We also find that CSN has unusually high affinity
for its reaction product, unmodified Cul1-Rbx1. Finally, we
document that CSN can also inhibit the ubiquitin ligase activity
of purified, unmodified SCF, pointing to a new and unexpected
role of CSN as a stoichiometric inhibitor of the activity of
deneddylated CRLs.
EXPERIMENTAL PROCEDURES
Purification of CSN—293F23V5 cells (gift from Z. Q. Pan,
Mount Sinai School of Medicine, New York) stably expressing
FLAG-Csn2 and Csn3-V5 were adapted to grow under suspen-
sion conditions in FreeStyle 293 expression medium (Invitro-
gen).When an approximate cell density of 5 105 cells/ml was
reached in a culture volume of 500 ml, the cells were pelleted,
washed once in cold PBS, pelleted again, and flash frozen in
liquid N2. CSN was affinity-purified using anti-FLAGM2 resin
(Sigma) as previously described (26), except binding occurred
over a 2-h period, 1 mM EDTA was used, EGTA was omitted,
and Complete Mini EDTA-free Protease Inhibitor Mixture
(Roche Applied Science) was used instead of individually add-
ing different inhibitors. Following affinity purification, CSN
was concentrated and immediately loaded onto a Superdex 200
gel filtration column equilibrated with 25 mM Tris, pH 7.5, 100
mM NaCl, 1 mM dithiothreitol, and 10% glycerol (storage
buffer). Fractions containing CSN were pooled, concentrated
with an Amicon Ultra-4 30-kDa molecular mass cut-off (Milli-
pore), and aliquoted for storage at80 °C.
Purification of Nedd8—The artificial gene His8-PKA-Nedd8
was designed to aid in the purification of in vitro neddylated
Cul1 and to be radiolabeled with 32P for quantitative enzymatic
analysis. The gene encoding the amino acid sequence MHHH-
HHHHHRRGSLMLIKVKTLTGKEIEIDIEPTDKVERIKERV-
EEKEGIPPQQQRLIYSGKQMNDEKTAADYKILGGSVLHL-
VLALRGG was purchased from DNA2.0 and put into their
expression plasmid pJexpress414. Expression was in BL21
(DE3) bacterial cells under ampicillin selection. 1-liter cultures
were grown at 37 °C until an A600 of 1.0 was reached. The
temperature was dropped to 16 °C before the addition of iso-
propyl -D-1-thiogalactopyranoside. Induction was carried out
at 16 °C overnight. Bacterial pellets were lysed by sonication in
a buffer containing 50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 2
mM dithiothreitol, and Complete Mini EDTA-free protease
inhibitor mixture (Roche Applied Science). The lysates were
clarified by centrifugation and incubated with 1.5 ml of nickel
beads (Qiagen) per pellet from a 1-liter culture. Binding to resin
was allowed to occur for 2 h at 4 °C. The resin was washed two
times with 50 column volumes of lysis buffer, followed by elu-
tion with 25mMTris, pH 7.5, 100mMNaCl, and 200mM imida-
zole. This mixture was then loaded onto a Superdex 75 gel fil-
tration column equilibrated in storage buffer composed of 25
mM Tris, pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, and 10%
glycerol. Fractions with His8-PKA-Nedd8 were concentrated,
and the purified protein was frozen at80 °C.
Expression and Purification of Recombinant Proteins—All
proteins as outlined in supplemental Table S3 were expressed
in either Escherichia coli or Hi5 insect cells and purified using
standard procedures. Ubxd7 was a gift from W. den Besten.
Dcn1 was a gift from B. Schulman (St. Jude, Memphis, TN).
CSN expressed and purified from E. coli was a gift from N.
Zheng (University of Washington, Seattle, WA). Phosphory-
lated Cyclin E-Cdk2 was a gift from B. Larimore (Clurman lab-
oratory, University of Washington, Seattle, WA).
In Vitro Neddylation Reaction—Cul1-Rbx1 was neddylated
with His8-PKA-Nedd8 (HPN8) using conditions previously
described (14), with the exception that His8-PKA-Nedd8 was
used at a concentration of 40 M. Cul1-Rbx1 conjugated with
HPN8 was purified by standard column chromatography tech-
niques, using first S-Sepharose, followed by binding to nickel
affinity matrix and then Superdex 200 gel filtration. For the
experiments shown in supplemental Fig. S1 (C and D), neddy-
lation reactions were terminated by the addition of 5 M
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MLN4924 and then diluted directly into a deneddylation
reaction.
In Vitro Deneddylation Reaction—Deneddylation reactions
in Figs. 2E and 3 were carried out with 0.8 nM CSN in a 1
deneddylation buffer containing 25 mM Tris, pH 7.5, 100 mM
NaCl, 1 mM dithiothreitol, 5% glycerol, and 1 ng/l ovalbumin.
Deneddylation reactions in Fig. 2A and supplemental Figs. S1,C
and D, and S3) were carried out with 1 nM CSN in deneddyla-
tion buffer containing 25 mM Tris, pH 7.5, 100 mMNaCl, 1 mM
DTT, 1% glycerol, 1 ng/l ovalbumin. Deneddylation reactions
in Fig. 2 (B–D) were carried out with 1 nM CSN in deneddyla-
tion buffer containing 25 mM Tris, pH 7.5, 50 mM NaCl, 1 mM
DTT, 1% glycerol, 15 ng/l ovalbumin 25 mM trehalose. See
figure legends for the time of reaction and the concentrations of
the reaction components. All of the reactions were performed
at room temperature (23–25 °C). Deneddylation reactionswere
quenched with reducing SDS-PAGE buffer and separated by
SDS-PAGE on 16% gels. The gels were dried and exposed to a
phosphor screen for analysis. Quantification was performed
with ImageQuant (GEHealthcare) and plotted usingGraphPad
Prism. All of the values reported are the averages of at least two
independent experiments. Rates of deneddylation were calcu-
lated by dividing the signal for free 32P-labeled HPN8 by the
summed signals for 32P-labeled HPN8-Cul1 and free HPN8 to
obtain the percentage of deneddylation. The amount of free
Nedd8 formedwas then calculated as: (%deneddylation) * (con-
centration of input HPN8-Cul1-Rbx1)/100. For the experi-
ments shown in Fig. 2 (A–D), initial rates were calculated
excluding the first 10 s, because of the apparent biphasic nature
of some of the reactions, which we ascribe to a small fraction of
Cul1 that did not assemble with F-box-Skp1 or substrate and
was therefore deneddylated more rapidly.
Ubiquitylation Reaction—All of the ubiquitylation reactions
were carried out as previously described (15) in a reaction
buffer composed of 25 mM Tris, pH 7.5, 100 mM NaCl, 5 mM
MgCl2, 2 mM ATP, 1 mM dithiothreitol. All of the reactions
were performed at room temperature (23 °C). See figure leg-
ends for the time of reaction and the concentrations of the
reaction components. Ubiquitylation reactions were quenched
with reducing SDS-PAGE buffer and separated on 16% Tris-
glycine SDS-PAGE gels. The gels were dried and exposed to a
phosphor screen for analysis. Quantification was performed
with ImageQuant (GEHealthcare) and plotted usingGraphPad
Prism. All of the values reported are the averages of at least two
independent experiments, except supplemental Fig. S4.
Cell Culture, Immunoprecipitation, and Western Blot—
HEK293T cells were obtained from ATCC and grown under
standard cell culture conditions in DMEM supplemented with
10% FBS. For transfection, Lipofectamine2000 was used
according to the manufacturer’s instructions (Invitrogen). A
description of the plasmids used in this study for transfection
and immunoprecipitation is provided in supplemental Table
S4. Twenty-four hours post-transfection, the cells were rinsed
in cold phosphate-buffered saline and lysed in 400M cold lysis
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EGTA,
0.1% Nonidet P-40, Complete Mini EDTA-free protease inhib-
itormixture (RocheApplied Science)). The lysates were cleared
by centrifugation at 12,000  g for 10 min at 4 °C, followed by
incubation with either anti-HA (Covance), anti-M2 FLAG
(Sigma), or anti-Myc (Covance) and 30l of Tris-Acryl protein
A (Pierce) at 4 °C for 2 hwith rotation. Resins were washed four
times with lysis buffer and resuspended in SDS sample buffer.
The proteins bound to resinwere resolved by SDS-PAGEon a 7,
10 or 12.5% gel. Immunodetectionwas performedwith antisera
to Cul1 and Skp1 (Invitrogen), Cand1 (Calbiochem), Cks1
(Invitrogen), Csn5 (Santa Cruz), Myc (Covance), and Rbx1/
Roc1 (BIOSOURCE).
RESULTS
We set out to characterize in depth the deneddylating activ-
ity of CSN by developing an in vitro assay in which the conver-
sion of neddylated Cul1 to Cul1 could be quantitatively mea-
sured. CSN was purified from HEK293 cells that stably express
the Csn2 subunit modified with an N-terminal FLAG tag (27).
CSN recovered from an anti-FLAG affinity column was further
enriched by gel filtration prior to being used for the experi-
ments described here. All eight subunits were found to be pres-
ent in the purified material, in apparently stoichiometric
amounts (Fig. 1A). Mass spectrometry analysis of purified CSN
identified two co-fractionating proteins (Ddb1 andHsp70) that
could not be totally removed by conventional methods such as
high salt or treatment with ATP and Mg2 (data not shown).
To develop a quantitative, multiturnover assay for deneddy-
lation, we first sought to generate a labeled form of Nedd8. To
this end, we fused a sequence encoding eight histidines fol-
lowed by a protein kinase A phosphorylation site to the N ter-
minus of Nedd8 to generate His-PKA-Nedd8 (HPN8). When
Cul1 was neddylated with HPN8 (HPN8-Cul1) and subse-
quently purified by gel filtration and nickel-nitrilotriacetic acid
chromatography, the resulting CSN substrate was 98% neddy-
lated as determined by SDS-PAGE (supplemental Fig. S1,A and
B). After radioisotope labeling with [32P]ATP and cAMP-de-
FIGURE 1. Characterization of in vitro deneddylation assay components
andenzymaticpropertiesofhumanCSN.A, purifiedCSN fromHEK293 cells
was fractionated by SDS-PAGE and analyzed by silver staining to check for
purity and stoichiometry of enzyme subunits. B, purified Cul1-Rbx1 (50 nM)
conjugated with 32P-labeled HPN8 was incubated with 1 nM CSN in a total
reaction volume of 50 l. At the indicated time points, the aliquots were
quenched and evaluated by SDS-PAGE followed by autoradiography.
C, PhosphorImager quantification of B. D, the initial rate of deneddylation by
0.8nMCSNatdifferent concentrationsof substrate is plotted.Km and kcatwere
estimated by fitting the curve to the Michaelis-Menten equation.
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pendent protein kinase, 97% of the total signal from Nedd8
was attached to Cul1 as determined by phosphorimaging (Fig.
1B; time 0). When CSN (1 nM) was added to HPN8-Cul1 (50
nM) and the reaction progress analyzed, deneddylation pro-
ceeded at a linear rate (Fig. 1, B and C).
Prior to performing kinetic analyses, we carried out a series of
control experiments. First we confirmed that the phosphory-
lated His-PKA tag had little to no effect on the rate of deneddy-
lation of Cul1 (supplemental Fig. S1C). Second, we compared
rates of deneddylation by our FLAG-tagged CSN prepared
from293 cellswith untaggedCSNexpressed in insect cells from
recombinant baculoviruses (supplemental Fig. S1D) and
untaggedCSN expressed in E. coli (28) (supplemental Fig. S1E).
The FLAG tag had no discernable effect on the activity of CSN
isolated from eukaryotic cells. Meanwhile, the enzyme purified
fromE. coliwas2-fold less active, possibly because of removal
of terminal sequences from some subunits to facilitate
expression.
To obtain enzymological metrics for CSN-mediated dene-
ddylation, we evaluated reaction rate as a function of substrate
concentration. CSN was held constant at 0.8 nM, and the initial
rates of deneddylation at varying concentrations of HPN8-
Cul1-Rbx1 were determined (supplemental Fig. S1F). The rates
for each concentration of substrate were plotted and fitted to
the Michaelis-Menten equation, which yielded a Km of 212 nM
and a kcat of 1.1 s1 (Fig. 1D) supplemental Table S1.
Within cells, the fraction of Cul1 that ismodified byNedd8 is
higher for Cul1 bound to F-box proteins (16, 17, 29). We rea-
soned that this might arise from differential rates of deneddy-
lation of Cul1, depending upon its assembly status. To test this
possibility, we compared rates of deneddylation for HPN8-
Cul1-Rbx1 versus three different HPN8-conjugated SCF
holoenzyme complexes. Deneddylation of HPN8-SCFFbw7 and
HPN8-SCFb-TrCP was assayed at 500 nM. Strikingly, Fbw7-Skp1
had a major effect, reducing the rate of deneddylation by 5.8-
fold (Fig. 2A). -TrCP-Skp1 had a weaker effect, reducing the
rate by 2.2-fold. However, the recombinant -TrCP used for
this experiment lacks the N-terminal 138 amino acids, which
were removed to facilitate efficient expression (30). Interest-
ingly, not all F-box proteins were inhibitory. Addition of Skp2-
FIGURE 2. F-box-Skp1 and substrate inhibit deneddylation by CSN. A, purified Cul1-Rbx1 (500 nM) conjugated with 32P-labeled HPN8 was preincu-
bated for 10 min with 600 nM of Fbw7-Skp1 or -TrCP-Skp1, followed by the addition of 1 nM CSN. At the indicated time points, aliquots were quenched
and evaluated by SDS-PAGE (left panel) followed by PhosphorImager quantification (right panel). The rates (fmol of Nedd8 released from Cul1/s) are
indicated to the right of each curve. The total reaction volume was 25 l. B, same as A, except 32P-labeled HPN8-Cul1-Rbx1 substrate at 50 nM was mock
incubated or preincubatedwith 100 nM Skp1-Skp2-Cks1 in the presence or absence of 1M phospho-p27-cyclin E-Cdk2 (p27). Total reaction volumewas
50 l. The asterisk indicates [32P] label incorporated into p27. C, same as A, except the 32P-labeled HPN8-Cul1-Rbx1 substrate was at 50 nM, Fbw7-Skp1
was at 100 nM, and phospho-cyclin E-Cdk2 (CycE) was at 500 nM. D, same as C, except that Fbw7-Skp1 was omitted. E, 32P-labeled HPN8-Cul1-Rbx1
substrate at 100 nM was preincubated 5 min with 300 nM Skp2-Skp1 plus or minus Cks1. Following assembly of SCFSkp2 complexes, the reactions were
supplemented with ubiquitylation components (1M ubiquitin, 400 nM E1, 100 nM Cdc34, plus or minus 500 nM phospho-p27-cyclin E-Cdk2), incubated
for 10 min, supplemented with ATP and Mg2 to initiate ubiquitylation, and incubated a further 20 min prior to addition of CSN (0.8 nM). The total
reaction volumewas 50l. At the indicated time points, aliquots were quenched and evaluated by SDS-PAGE followed by phosphorimaging (top panel).
Quantification of the phosphorimaging scans is shown in the bottom panel.
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Cks1-Skp1 reduced the rate of deneddylation by 20% (Fig.
2B). We do not understand the basis for this difference in
behavior but note that endogenous Cul1 co-precipitated with
transiently expressed F-box proteins was 50% neddylated in
-TrCP and Fbw7 immunoprecipitates but considerably less
modified in Skp2 immunoprecipitates (supplemental Fig. S2, A
and B, and data not shown).
In other work we have shown that a mutant of Skp1
(Skp1) used for crystallography (31) that lacks two acidic
internal loops was able to bind Cul1-Rbx1 and assemble an
active SCF complex but was unable to promote displacement of
Cand1 fromCul1-Rbx1 (32).5 Because Fbw7-Skp1 had themost
potent effect on deneddylation, we tested the impact of the
Skp1 loops in this context. Interestingly, the loop deletions
reduced the inhibitory effect of Fbw7-Skp1 by 2.5-fold (sup-
plemental Fig. S3). However, the acidic loops of Skp1 were not
sufficient to specify inhibition of deneddylation, because our
Skp2-Cks1-Skp1 contained wild type Skp1.
Given the substantial effect of Fbw7-Skp1 on deneddylation,
we next sought to test whether binding of substrate to Fbw7
might further influence deneddylation of the associatedHPN8-
Cul1. There is good reason to think this might be the case; Cul1
co-precipitated from cells with SCF substrates is essentially
100% neddylated (16), implying that substrate might either
increase the rate of neddylation or decrease the rate of dene-
ddylation above and beyond the effect of the F-box protein.
Consistent with this possibility, the addition of the Skp2-Cks1
substrate p27kip1 to SCFSkp2-Cks1 complexes in fractionated cell
lysate decreases Cul1 deneddylation (33). However, because
this experiment was carried out with undefined protein frac-
tions, a clear explanation for this phenomenon remains lacking.
To test the effect of substrate in a defined system, we com-
pared the rate of deneddylation of HPN8-SCFFbw7 in the pres-
ence and absence of full-length phospho-cyclin E bound to
Cdk2. Cyclin E must be phosphorylated on at least two sites
(T-380 and S-384) to serve as a substrate for SCFFbw7 (34). The
addition of phospho-cyclin E-Cdk2 further reduced the rate of
deneddylation of HPN8-SCFFbw7 by 2.5-fold (Fig. 2C). The
effect of substratewas specific, because phospho-cyclin E-Cdk2
had no effect on the rate of deneddylation of HPN8-Cul1 in the
absence of Fbw7-Skp1 (Fig. 2D). Together, Fbw7 plus phospho-
cyclin E reduced deneddylation by 10-fold. Note that this
experiment was done with 50 nM substrate, in contrast to Fig.
2A, which was done with 500 nM. Thus, the inhibitory effect of
Fbw7-Skp1 on deneddylation of HPN8-Cul1 was similar when
CSNwas either subsaturated or nearly saturatedwith substrate.
To determine whether the effect of substrate applies to other
SCF complexes, we tested the effect of phospho-p27-cyclin
E-Cdk2 substrate on HPN8-SCFSkp2-Cks1. The addition of sub-
strate reduced the rate of deneddylation by2.3-fold (Fig. 2B),
similar to what was seen in Fig. 2C. A similar magnitude of
substrate-mediated inhibition was observed when SCFSkp2
complexes were assayed in the presence of phospho-p27-cyclin
E-Cdk2 under conditions that were permissive (Cks1) or not
permissive (Cks1) for substrate binding and ubiquitylation
(Fig. 2E). Taken together, these results imply that substrate
reduced the rate of deneddylation equivalently regardless of
whether or not it was undergoing ubiquitylation.
Cullin deneddylation in vivomust occur in the presence of a
substantial concentration of unmodified cullins as well as a
large constellation of factors that bind cullins, any one of which
might have an impact on the rate of deneddylation. To address
this issue, we evaluated deneddylation of HPN8-Cul1-Rbx1 in
the presence of different recombinant proteins purified from
E. coli and added at a fixed concentration of 1 M. Neddylated
substrate was mixed with each potential regulator and allowed
to interact for 5 min at room temperature before CSN was
added, and the reaction progress was monitored. Interestingly,
every single factor that was tested reduced the rate of deconju-
gation of HPN8 from substrate. The factors tested fell into two
categories based on their ability to repress CSN deneddylase
activity: moderate inhibitors (Ubc12, Dcn1, UbcH5C, and
Nedd8), which repressed deneddylation by 2.2–4.8-fold, and
strong inhibitors (Cul1, Ubxd7, Cdc34, and Cand1), which
repressed deneddylation between 7.2- and 14.4-fold (Fig. 3A).
Supplemental Table S2 contains initial rates of deneddylation
in the presence of each factor tested. Based on these results, we
pursued in more detail the inhibition of deneddylation by
Cand1 and unmodified Cul1-Rbx1.
Cand1 was previously reported to interact exclusively with
unmodified cullins, including Cul1-Rbx1 (35, 36). Consistent
with this, the co-crystal structure of Cul1-Rbx1-Cand1 showed
that the Nedd8 conjugation site of Cul1 is partially obscured by
Cand1 (32). Moreover, the crystal structure of Nedd8 conju-
gated to the C-terminal domain of Cul5 showed how a Nedd8-
induced conformational change blocks binding of the N-termi-
nal domain of Cand1 (14). Therefore, we were surprised to find
that Cand1 was a potent inhibitor of deneddylation (Fig. 3A).
We investigated this property further in our in vitro deneddy-
lation assay by keeping the concentrations ofHPN8-Cul1-Rbx1
substrate (150nM) andCSNenzyme (0.8 nM) constant and vary-
ing the concentration of Cand1. This experiment yielded an
apparent inhibition constant of 160 nM (Fig. 3B). Two lines of
evidence suggest that Cand1 inhibited deneddylation by bind-
ing substrate: the addition of Cand1 increased the Km but did
not affect the kcat for deneddylation of HPN8-Cul1 (Fig. 3C),
and Cand1 exhibited no effect on the initial rate of deneddyla-
tion of HPN8-SCFSkp2-Cks1 (Fig. 3D). These data suggest that
binding of the C-terminal domain of Cand1 to the N-terminal
domain of Cul1 (which is blocked by Skp1-Skp2-Cks1) inter-
fereswith recruitment ofCSN.Notably, inAspergillus, Cand1 is
naturally split into two polypeptides, and the polypeptide cor-
responding to the C-terminal portion of human Cand1 can
bind Cul1 in the absence of the N-terminal portion (37).
CSN was also strongly inhibited by its reaction product,
unmodified Cul1-Rbx1 (Fig. 3A). We determined the IC50 for
Cul1 to be 260 nM when assayed at 50 nM substrate (Fig. 3E).
This suggests that the Nedd8 modification must not confer a
large amount of affinity for CSN, which is consistent with our
observation that free Nedd8 was a weak inhibitor of deneddy-
lation (Fig. 3A). The surprisingly strong apparent affinity of
unmodified Cul1-Rbx1 product for CSN is consistent with our
original discovery that CSN associates with a mutant Cul1 that5 N. Pierce and R. J. Deshaies, unpublished data.
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lacks the extreme C terminus including the Nedd8 conjugation
site (10) and raises the possibility that product dissociation
might be rate-limiting for substrate deneddylation.
To conclusively demonstrate that CSN can form a stable
interaction with unmodified SCF, we mixed purified CSN with
purified SCFSkp2-Cks1 and fractionated the mixture on a Super-
dex 200 size exclusion column. SCFSkp2-Cks1 that was notmixed
withCSNwas used for comparison purposes. In the presence of
CSN, a fraction of the SCFSkp2-Cks1 molecules was shifted to
higher molecular weight fractions, corresponding to fractions
that contained CSN (Fig. 4A).
To test whether unmodified full-length Cul1 (i.e., the prod-
uct of deneddylation) exhibits significant binding to CSN in
cells, we transiently transfected HA epitope-tagged wild type
and K720R Cul1 expression constructs into HEK293 cells.
K720R lacks the site on Cul1 to which Nedd8 is conjugated.
Twenty-four hours post-transfection, the cells were lysed, and
the HACul1 was immunoprecipitated with HA antibody. The
immunoprecipitateswere then immunoblottedwith antibodies
to detect HACul1 as well as the endogenous Skp1, Rbx1, Csn5,
and Cand1 proteins (Fig. 4B). Whereas wild type and K720R
HACul1 were expressed at similar levels and bound similar
amounts of Rbx1 and Skp1, the K720R mutant actually
retrieved more Csn5 than wild type. By comparison, a recent
proteomic study reported equivalent association of CSN with
wild type and K720R-Cul1 in HEK293T cells (38). As indepen-
dent confirmation of this result, we examined the interaction of
endogenous Cul1 with transiently expressed FLAG-tagged
Csn5. Cul1 co-immunoprecipitated with FLAGCsn5 was exclu-
sively in the unconjugated form (Fig. 4C). Even if deconjugation
occurred within the CSN-SCF complex in vitro, this result
emphasizes the point that unlike traditional enzymes, CSN did
not rapidly let go of its substrate upon deconjugating it. To
more directly compare the association of CSN with neddylated
and unmodified Cul1, we repeated this experiment with
FLAGCsn5-ASA, which is mutated for two of the histidine resi-
dues that play a critical role in forming the active site thatmedi-
ates deneddylation (12, 39). Althoughmost of the endogenous
Cul1 that co-immunoprecipitated with FLAGCsn5-ASA was
modified with Nedd8, a substantial pool of unmodified Cul1
was recovered, confirming that unmodified cullin substrate
can associate stably with CSN. Finally, to explore structure-
activity relationships in greater depth, we also evaluated
binding of endogenous CSN to HACul1 variants that could
FIGURE 3. Proteins that bind the C-terminal domain of Cul1 inhibit deneddylation. A, 32P-labeled HPN8-Cul1-Rbx1 (25 nM) was incubated for 10min with
1M of the indicated factor prior to addition of 0.8 nM CSN. At the indicated time points, the aliquots were quenched and evaluated by SDS-PAGE followed by
PhosphorImager quantification. The total reaction volumewas 40l. B, same as A, except that substrate was 150 nM andwas preincubatedwith the indicated
final concentration of Cand1 prior to adding CSN. C, same as B, except that Cand1 (250 nM) and CSN (0.8 nM) were held constant, whereas the concentration of
substratewas varied. The datawere fitted to theMichaelis-Menten equation to estimate kcat and Km.D,
32P-labeledHPN8-Cul1-Rbx1 (50 nM)was preincubated
with 200 nM Skp1-Skp2-Cks1 for 10min prior to addition of the indicated final concentrations of Cand1. Following a further 10min of precincubation, CSN (0.8
nM) was added. At the indicated time points, the aliquots were quenched and evaluated by SDS-PAGE followed by PhosphorImager quantification. E, same as
B, except that substrate was 50 nM and Cul1-Rbx1 was titrated.
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not bind to Skp1 and Rbx1. Thesemutants were generated by
using the x-ray crystal structure of SCF as a guide (40). Both
of these mutants bound less Csn5 (Fig. 4B). The failure of the
RING-deficient mutant to bind CSN is consistent with the
original finding that Csn2 binds Rbx1 in a yeast two-hybrid
assay (10). Taken together, our data suggest that CSN exhib-
its a complex mode of interaction with Cul1 that is not
dependent on Nedd8 and involves both ends of the elongated
CRL complex.
Stable binding to substrate and/or product is unusual for an
enzyme and suggested to us that CSN might regulate CRLs by
mechanisms other than deconjugation of Nedd8. This possibil-
ity is further supported by our observation thatmultiple factors
that interact with Cul1, including the E2 enzymes UbcH5C and
Cdc34, inhibited deneddylation of HPN8-Cul1-Rbx1. We
therefore set out to test whether CSN can inhibit SCF activity,
independently of its effects on Nedd8 conjugation. An ubiqui-
tylation reaction was set up that contained unmodified
SCFTrCP plus radiolabeled -catenin peptide, ubiquitin, E1,
and either UbcH5C or Cdc34. The ubiquitylation reaction was
initiated by the addition of ATP and Mg2 followed by the
addition or omission of 300 nM CSN (which is slightly less than
the estimated in vivo concentration of 500 nM in 293 cells) (38).
The addition of CSN resulted in a 3.4–3.8-fold reduction in the
rate of substrate conversion to products, independent of the E2
that was employed (Fig. 5). Inclusion of CSN affected both the
extent of substrate conversion as well as the pattern of reaction
products thatwere produced, indicating thatCSNaffected both
ubiquitin chain initiation and elongation.
UbcH5 and Cdc34 catalyze SCF-dependent substrate ubiq-
uitylation with Km values that differ by approximately an order
of magnitude (15). Their equivalent sensitivity to inhibition by
CSN suggested that CSN might not compete with E2 for bind-
ing to unmodified SCF. Consistent with this, 300 nM CSN
exerted a similar fold inhibition of ubiquitylation in reactions
that contained either 1 or 10 M Cdc34 (supplemental Fig.
S4A).We also evaluatedwhetherCSNmight competewith sub-
strate. Regardless of whether cyclin E peptide substrate was
present at 0.1 or 1 M, 300 nM CSN inhibited SCFFbw7 to a
similar degree (supplemental Fig. S4B).
DISCUSSION
CSN mediates deneddylation of all cullins in vivo. However,
the quantitative kinetic parameters of CSN-mediated deneddy-
lation have remained largely unknown, in part because of the
complexity of the enzyme and its substrate. In this work, we
developed reagents and methods that enabled us to measure
quantitatively the deconjugation of radiolabeled Nedd8 from a
purified Nedd8-Cul1-Rbx1 substrate. Here, we consider the
implications of our quantitative measurements for the physio-
logical function of CSN.
Affinity of CSN for Substrate and Product—Our studies
reveal that CSN has high affinity (Km  212 nM) for Cul1 sub-
strate. We do not know the KD for the interaction, but given
that kcat/Km is in the diffusion-limited range, it is possible that
KD is considerably lower than Km. Contrary to what has been
suggested elsewhere (42), we also show that deneddylated cullin
binds tightly with CSN, although not quite as tightly as neddy-
lated substrate. At least four lines of evidence support this
claim: 1) CSN activity was significantly inhibited by unmodified
Cul1-Rbx1, with an IC50 of 260 nM (Fig. 3E); 2) unmodified
SCFSkp2-Cks1 was shifted to higher molecular weight fractions
on a Sephadex 200 size exclusion column in the presence of
CSN (Fig. 4A); 3) Csn5 stably co-precipitated with a mutant
of Cul1 that cannot be neddylated (Fig. 4B); and 4) deneddy-
lated Cul1 co-precipitated with both wild type Csn5 and a
mutant that lacks deneddylase activity (Fig. 4C). These data add
FIGURE 4.CSN forms a stable complexwith bothneddylated andunmod-
ified Cul1. A, purified SCFSkp2-Cks1 (600 nM)was incubated for 15min in either
thepresence (toppanel) or theabsence (bottompanel) of 300nMpurifiedCSN.
Complexes were passed through a Sephadex 200 size exclusion column, and
every third fraction was separated by SDS-PAGE and Western blotted with
antisera to the indicatedproteins. B, the indicatedHA-taggedCul1 constructs
were transfected into HEK293 cells. Twenty-four hours post-transfection, the
lysates were generated, and HACul1 was immunoprecipitated with anti-HA
antibody. Immunoprecipitates were fractionated by SDS-PAGE and Western
blotted with antisera to the indicated proteins. Cul1 was detected with anti-
HA. xRING and xSkp1 refer to point mutants of Cul1 that were deficient in
binding Rbx1 and Skp1, respectively. K720R has an arginine . substitution at
the Nedd8 conjugation site (lysine 720). C, the indicated FLAG-tagged Csn5
constructs were transfected into HEK293 cells. Twenty-four hours post-trans-
fection, the lysates were generated, and FLAGCsn5 was immunoprecipitated
(IP) with anti-FLAG antibody. Immunoprecipitates were fractionated by SDS-
PAGE and Western blotted with antisera to Csn5 and Cul1 as indicated. EV
refers to empty vector. ASA refers to a double pointmutation that inactivates
the JAMM domain of Csn5.
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to a considerable body of evidence that CSN binds tightly to its
reaction product. Indeed, the role of CSN in CRL biology was
first discovered based on its efficient co-immunoprecipitation
with a C-terminal truncation mutant of Cul1 that lacks the
lysine 720 to which Nedd8 is conjugated (10). In the recent
quantitative proteomic study of Bennett et al. (38), they
reported that even in the absence of Nedd8 conjugation
(brought about by the addition of theNedd8 conjugation inhib-
itor MLN4924 to cells), nearly 50% of Csn6 remains associated
with cullins 1–5.
Given the surprisingly tight binding of unmodified Cul1 to
CSN and the total relative concentrations of CSN (500 nM) and
Cul1-Cul5 (1250 nM) in cells (38), of which we estimate based
on data shown in Ref. 39 that35% (450 nM) is neddylated, it
is plausible that the entire cellular pool of CSN is essentially
saturated with neddylated and unmodified cullins. Indeed,
based on the mole fraction of Csn6 that is bound to individual
cullins, up to 60% of CSN remains associated with cullins fol-
lowing immunoprecipitation (38). It is a reasonable possibility
that most of the remaining 40% of CSN was also bound to
cullins in cells but dissociated during the preparation and
washing of the immunoprecipitates. Thus, it is possible that
in cells, dissociation of CSN from CRLs is rate-limiting for
deneddylation.
Catalytic Rate of CSN—At saturating concentrations of
Nedd8-modified Cul1 substrate, the maximal rate of CSN-
mediated deneddylation is 1 s11, Although reasonably
fast, this kcat is 100-fold slower than the maximal rate of
cleavage of the model substrate CbzGly-L-Phe by the zinc
metalloprotease carboxypeptidase A (43). What is puzzling
about the multiturnover rate of 1 s1 is that it implies that
the rate of product dissociation must be at least this fast.
However, this is difficult to reconcile with the observations
noted in the prior section that CSN binds to deneddylated
CRLs with sufficient stability to survive gel filtration or
immunoprecipitation. Resolution of this conundrum will
require further experimentation.
A notable feature of the neddylation cycle is the rate at which
it proceeds in cells. Application of the Nedd8 conjugation
inhibitor MLN4924 to cells results in rapid loss of Nedd8 con-
jugates; although quantification was not reported, a conserva-
tive estimate is that 80% of neddylated cullins are consumed
within 5 min (3). This represents a minimal rate for deneddyla-
tion, because earlier time pointswere not evaluated, and it takes
a finite amount of time for the drug to penetrate cells and effect
depletion of the pre-existing pool of Ubc12Nedd8 thioesters.
Regardless, this rate is easily achievable. At the estimated cellu-
lar concentrations of CSN and total Nedd8-conjugated cullins
(500 and 450 nM, respectively) and the kcat/Kmfor deneddyla-
tion reported here (5 106 M1 s1), the pool of cullins could
be extensively deneddylatedwithin several seconds upon extin-
guishing Nedd8 conjugation activity.
Inhibition of Deneddylation by F-box Proteins, Substrates,
and Other Cul1-binding Factors—A key finding of this manu-
script is that binding of F-box-Skp1 complexes to Cul1 can
substantially reduce the rate of deneddylation. Fbw7-Skp1
slowed deneddylation by5-fold, and this effect was increased
to10-fold upon the addition of phospho-cyclin E-Cdk2 sub-
strate. Thus, in the environment of the cell where CSN is essen-
tially saturated with neddylated and unmodified cullins, fully
FIGURE 5. CSN inhibits ubiquitylation by unmodified SCF. A, SCFTrCP (100 nM) and ubiquitylation components (1M ubiquitin, 400 nM E1, 100 nM UbcH5C,
600 nM 32P-labeled-phospho- catenin peptide) were incubated either in the presence or absence of 300 nM CSN for 10 min, after which ubiquitylation
reactions were initiated by the addition of ATP and Mg2. Time points were harvested at the indicated times, fractionated by SDS-PAGE, and subjected to
PhosphorImager quantification. B, same as A, except that 100 nM Cdc34 was used in place of UbcH5C.
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assembled SCF complexes that are engaged with substrate are
expected to be comparatively immune to the action of CSN.
This has important implications for the regulation of SCF com-
plex deactivation and disassembly. Accumulation of substrate
for a particularCRL complexwould be expected to lead to accu-
mulation of theNedd8-conjugated formof that complex (Fig. 6,
step 1). Upon consumption of the substrate (Fig. 6, step 2), the
CRL complexwould either be subject to autoubiquitylation and
degradation of the substrate receptor (Fig. 6, step 5) or recruit
CSN and be deneddylated (Fig. 6, step 3). Reappearance of sub-
strate would lead to displacement of CSN (Fig. 6, step 4) and
re-formation of neddylated, active complex (Fig. 6, step 1). By
this mechanism, CRL complexes for which substrate is present
would be preferentially neddylated and activated. In the
absence of CSN (Fig. 6, gray zone), this regulation would be
undermined, and upon depletion of substrate for a particular
CRL, the complex would remain conjugated to Nedd8 and
active (Fig. 6, step 2), leading to autoubiquitylation and ulti-
mately degradation of the substrate receptor and inactivation of
the CRL (Fig. 6, step 5). We speculate that substrate adaptors
that are most prone to become ubiquitinated in the absence of
bound substrate will be the most sensitive to a loss of CSN
function. Several important questions remain unanswered by
this model. For example, how do F-box proteins and substrates
inhibit deneddylation? Why does Fbw7-Skp1 but not Skp2-
Cks1-Skp1 potently inhibit deneddylation?How does Cand1 fit
into this cycle?
In addition to Fbw7-Skp1, which interacts with the N-termi-
nal domain of Cul1, every factor that is known to contact Rbx1
and/or the C-terminal domain of Cul1 that was tested here
(UbcH5c, Cdc34, Ubc12, Dcn1, Ubxd7, and Cand1) also inhib-
its deneddylation of Cul1 by CSN to some extent.We conclude
that CSN is likely tomake extensive contacts with Rbx1 and the
C-terminal domain of Cul1. Our observation that Cand1 inhib-
its deneddylation is in direct conflict with a report to the con-
trary (44). We do not understand the reason for the discrep-
ancy, but note that those authors measured deneddylation in a
buffer that is completely lacking salt.We also draw attention to
the inhibition of deneddylation byUbxd7. Ubxd7 binds directly
to theNedd8modification via an internal UIMdomain (45, 46).
Overexpression of Ubxd7 can cause accumulation of Nedd8-
conjugatedCul2, suggesting that it can shieldCul2 fromCSN in
vivo.
CSN Inhibits CRL Activity by Catalytic and Noncatalytic
Mechanisms—CSN initiates deactivation of a neddylated CRL
complex by reversing the Nedd8 modification. The deconju-
gated CRL has severalfold less ubiquitin ligase activity (14–17).
We suggest that in some instances, CSN remains stably bound
to its product, and this reduces ubiquitin ligase activity even
further. To investigate this possibility, we evaluated the effect of
CSN on the basal activity of SCF that was not neddylated.
Remarkably, 300 nM CSN (which is lower than its intracellular
concentration) inhibited unmodified SCF by up to 3.5-fold.
Equivalent inhibition of unmodified SCF occurred regardless of
whether Cdc34 or UbcH5was used as the E2 or whether Cdc34
was added at 0.1 (not shown), 1, or 10 M. These observations
suggest that the noncatalytic inhibitory activity of CSNwas not
competitive with respect to E2, even though E2 was able to
inhibit deneddylation of HPN8-Cul1 by CSN. Likewise, CSN
exhibited equivalent inhibition of SCFFbw7 when assays were
conducted with 0.1 or 1 M cyclin E peptide substrate. We
suggest that the E3 inhibition is a kcat effect that arises because
CSN restrains SCF in a low activity conformation. Regardless of
the exact mechanism, noncatalytic regulation is likely to be
physiologically relevant, because nearly 30% of Cul1 and40%
of Cul4B are stably bound to CSN in 293T cells (38). Indeed,
genetic studies implicated fission yeast Csn1 and Csn2, but not
Csn5, as being required for a specific function of CRL4 (47), and
a recent publication reported that expression of catalytically
inactive Csn5 partially restores proper CRL regulation in a
Neurospora mutant that lacks Csn5 (48).
While thismanuscript was being drafted, it was reported that
CSN potently inhibits autoubiquitylation of substrate receptor
subunits within CRL4ADDB2 and CRL4ACSA complexes (49).
Remarkably, this inhibition was relieved by the addition of a
ligand for the substrate receptor. This suggests that binding of
ligand/substrate to the CSN-CRL4A complex activates CRL4A
by facilitating dissociation of CSN. Interestingly, CRL4ACSA
efficiently polyubiquitinates its substrateCSB in the presence of
CSN. Although this is in apparent conflict with our results, the
kinetics of CSB ubiquitylation were not evaluated in the pres-
ence and absence of CSN, so it is possible that CSN retards
ubiquitylation of CRL4A substrates much as it does for SCF as
shown here.
Improvements in biochemical assay methods (15, 50–52)
and mass spectrometry-based quantification (38, 53) have
begun to give us amuch clearer picture of the numerical param-
eters that govern the ubiquitin ligase activity of CRLs and the
mechanisms that regulate this activity. Systematic pursuit of
these approaches, coupled with structural biology and enzy-
mology, promises to reveal a detailed picture of how these
enzymes work, how their activities are controlled, and how
these features relate to their physiological roles in cells. We
FIGURE 6. Regulation of CRLs by reversible neddylation. See text for
details. Transitionsmarkedby single arrows are vectorial. The intermediates at
steps 5 and 6 could re-form new CRL complexes by binding a different sub-
strate receptor-adaptor module (dashed and curved lines, respectively).
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propose that this information will enable researchers to
make good on the promise of basic science by developing
novel medicines that target CRLs. Already, encouraging
steps have been made in that direction (3, 41, 54, 55), and we
can only hope, for the sake of patients, that there will bemore
to follow.
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